Co-diagnostics, inc. test performance demonstrated by australian researchers in peer-reviewed publication

Salt lake city, april 20, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its logix smart™ covid-19 test kit was used by australian researchers to demonstrate rapidly deployable mobile molecular diagnostics support for remote locations, with the peer-reviewed results published in the journal of medical microbiology. the test demonstrated an analytical sensitivity of 1010 viral copies/ml, comparable to others used across w.
CODX Ratings Summary
CODX Quant Ranking